郑伟鹤于2026年9月3日以每股均价3.6394港元卖出银诺医药-B股份375.00万股,涉资约1364.78万港元。
郑伟鹤此次减持前持有银诺医药-B好仓3294.11万股,占比7.84%;减持后持股量为2919.11万股,好仓比例降至6.95%。
郑伟鹤于2026年9月3日以每股均价3.6394港元卖出银诺医药-B股份375.00万股,涉资约1364.78万港元。
郑伟鹤此次减持前持有银诺医药-B好仓3294.11万股,占比7.84%;减持后持股量为2919.11万股,好仓比例降至6.95%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.